2020
DOI: 10.1111/ajad.13053
|View full text |Cite
|
Sign up to set email alerts
|

Disentangling the Social Context of Nonmedical Use of Prescription Stimulants in College Students

Abstract: Background and Objectives The aim of this study was to investigate the social context of nonmedical use of prescription stimulants (NMUPS) among college students who endorsed NMUPS with co‐occurring substance use disorders (SUD) compared with those without co‐occurring SUDs. Methods Presented here are new analyses based on data previously collected from college students aged 18 to 28 years derived from the Boston metropolitan area who endorsed NMUPS (N = 100) at least once in their lifetime. Differences betwee… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
4
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 33 publications
2
4
0
Order By: Relevance
“…Concurrent substance use with prescription stimulant NMU has been reported previously ( Compton et al, 2018 , Faraone et al, 2019 , Schepis et al, 2020 , Arria et al, 2013 , Wilens et al, 2020 , McCabe et al, 2015 ). In particular, alcohol and prescription stimulant use among college students was associated with negative outcomes ( Schepis et al, 2019 ).…”
Section: Resultssupporting
confidence: 53%
“…Concurrent substance use with prescription stimulant NMU has been reported previously ( Compton et al, 2018 , Faraone et al, 2019 , Schepis et al, 2020 , Arria et al, 2013 , Wilens et al, 2020 , McCabe et al, 2015 ). In particular, alcohol and prescription stimulant use among college students was associated with negative outcomes ( Schepis et al, 2019 ).…”
Section: Resultssupporting
confidence: 53%
“…Prescription stimulant NMU has been associated with a number of risks that have been epidemiologically reported including behavioral risks such as possible off-label use (Burcu et al, 2016), diversion (Compton et al, 2018; Han et al, 2017), or dating violence (Whiteside et al, 2015), health risks such as aortic dissection (Westover & Nakonezny, 2010), acute myocardial infarction (Westover et al, 2008), or psychiatric disorders (Wilens et al, 2020) among others (Faraone et al, 2019, 2020). While the existence of non-oral NMU is well-documented, details surrounding use with specific routes of administration (ROAs) are less well understood.…”
Section: Discussionmentioning
confidence: 99%
“…Reports of NMU persist in the scientific literature and in the popular press (Arria et al, 2011; Faraone et al, 2020; Friedman, 2010; Garnier-Dykstra et al, 2012; Italiano, 2011; McCabe & West, 2013; McCabe et al, 2004, 2005, 2006b, 2009; Peltz, 2012; Pratt-Kielley, 2020; Schepis, Ford et al, 2020; Schepis, Klare et al, 2020; Swanson & Volkow, 2008; Wilens et al, 2020). Prescription stimulant NMU has been associated with a number of risks that have been epidemiologically reported including behavioral risks such as possible off-label use (Burcu et al, 2016), diversion (Compton et al, 2018; Han et al, 2017), or dating violence (Whiteside et al, 2015), health risks such as aortic dissection (Westover & Nakonezny, 2010), acute myocardial infarction (Westover et al, 2008), or psychiatric disorders (Wilens et al, 2020) among others (Faraone et al, 2019, 2020). While the existence of non-oral NMU is well-documented, details surrounding use with specific routes of administration (ROAs) are less well understood.…”
Section: Introductionmentioning
confidence: 99%
“…Participants were recruited because they had used prescription stimulants non-orally, a risk factor for substance use severity (57,66). For example, the speed of transition from first use to daily heroin was faster if the initial use was non-oral (injection) (58).…”
Section: Route Of Administration Transitionsmentioning
confidence: 99%
“…Prescription stimulant NMU route of administration transitions may include moving between oral and non-oral routes of administration (26,60). Prescription stimulant substance transitions would involve moving on to other substances after prescription stimulant NMU, a trajectory that is possible among individuals with polysubstance use; a characteristic reported in individuals endorsing prescription stimulant NMU (61)(62)(63)(64)(65)(66).…”
Section: Introductionmentioning
confidence: 99%